FDA Inspection 701582 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA completed an inspection of IPR Pharmaceuticals, Inc. on December 7, 2010 in Canovanas, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 7, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)